We are live on ! Find out more
CRBU icon

Caribou Biosciences
CRBU

88 hedge funds and large institutions have $704M invested in Caribou Biosciences in 2021 Q3 according to their latest regulatory filings, with 88 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50.13% more ownership

Funds ownership: 0% → 50.13% (+50%)

Holders
88
Holders Change
+88
Holders Change %
–
% of All Funds
1.54%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.09%
New
88
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$100M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$81.2M
3
FCM
Farallon Capital Management
California
+$72.4M
4
APM
Avidity Partners Management
Texas
+$60.5M
5
Alkeon Capital Management
Alkeon Capital Management
New York
+$30.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
26
Sphera Funds Management
Israel
$4.77M +$4.89M +200,000 New
DKCM
27
Davidson Kempner Capital Management
New York
$4.38M +$4.49M +183,600 New
Northern Trust
28
Northern Trust
Illinois
$4.13M +$4.23M +173,001 New
GIM
29
Granahan Investment Management
Massachusetts
$3.39M +$3.47M +141,951 New
SCM
30
Shelton Capital Management
Colorado
$3.29M +$3.37M +138,000 New
Charles Schwab
31
Charles Schwab
California
$3.18M +$3.26M +133,277 New
ACH
32
ArrowMark Colorado Holdings
Colorado
$2.98M +$3.06M +125,000 New
WP
33
Woodline Partners
California
$2.85M +$2.92M +119,273 New
LCM
34
Laurion Capital Management
New York
$2.75M +$2.81M +115,000 New
CCM
35
CAAS Capital Management
New York
$2.39M +$2.44M +100,000 New
Victory Capital Management
36
Victory Capital Management
Texas
$2.03M +$2.08M +84,930 New
MAM
37
Mark Asset Management
New York
$1.91M +$1.96M +80,000 New
EC
38
EcoR1 Capital
California
$1.79M +$1.83M +75,000 New
GCM
39
Ghisallo Capital Management
Massachusetts
$1.79M +$1.83M +75,000 New
Squarepoint
40
Squarepoint
New York
$1.79M +$1.83M +75,000 New
Millennium Management
41
Millennium Management
New York
$1.78M +$1.83M +74,674 New
N
42
Nuveen
North Carolina
$1.57M +$1.61M +65,788 New
Teacher Retirement System of Texas
43
Teacher Retirement System of Texas
Texas
$1.43M +$1.47M +60,000 New
NCM
44
Nantahala Capital Management
Connecticut
$1.35M +$1.38M +56,418 New
Morgan Stanley
45
Morgan Stanley
New York
$1.26M +$1.29M +52,756 New
Bank of New York Mellon
46
Bank of New York Mellon
New York
$1.15M +$1.18M +48,131 New
PVI
47
Pura Vida Investments
New York
$1.04M +$1.07M +43,639 New
MCM
48
Moore Capital Management
New York
$988K +$1.01M +41,393 New
Bank of America
49
Bank of America
North Carolina
$821K +$840K +34,375 New
GAA
50
Green Alpha Advisors
Colorado
$784K +$803K +32,836 New
1
2
3 4

CRBU Hedge Fund Activity: Q3 2021 in Review

88 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q3 2021, worth a combined $704M.

Buyers outnumbered sellers: 88 funds opened new CRBU positions and 0 closed out — a net gain of 88 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was PFM Health Sciences, opening a new position worth an estimated $100M.

  • 88 institutional investors held Caribou Biosciences (CRBU) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $704M of Caribou Biosciences stock for Q3 2021.
  • 88 funds opened new Caribou Biosciences positions in Q3 2021 and 0 closed out, a net change of +88 holders.
  • The largest Caribou Biosciences buyer in Q3 2021 was PFM Health Sciences, an estimated $100M added.

Based on aggregated 13F filings for Q3 2021.